Orphanin FQ/Nociceptin Activates Nuclear Factor Kappa B

Anton B, Leff P, Meissler JJ, Calva JC, Acevedo R, Salazar A, Matus M, Flores A, Martinez M, Adler MW, Gaughan JP, Eisenstein TK (2010) Nociceptin/orphanin FQ suppresses adaptive immune responses in vivo and at picomolar levels in vitro. J Neuroimmune Pharmacol 5:143–154 Arjomand J, Cole S, Evans CJ (2002) Novel orphanin FQ/nociceptin transcripts are expressed in human immune cells. J Neuroimmunol 130:100–108 Bian X, McAllister-Lucas LM, Shao F, Schumacher KR, Feng Z, Porter AG, Castle VP, Opipari AW Jr (2001) NF-kappa B activation mediates doxorubicin-induced cell death in N-type neuroblastoma cells. J Biol Chem 276:48921–48929 Bidlack JM, Khimich M, Parkhill AL, Sumagin S, Sun B, Tipton CM (2006) Opioid receptors and signaling on cells from the immune system. J Neuroimmune Pharmacol 1:260–269 Boulanger LM (2009) Immune proteins in brain development and synaptic plasticity. Neuron 64:93–109 Bui NT, Livolsi A, Peyron JF, Prehn JH (2001) Activation of nuclear factor kappaB and Bcl-x survival gene expression by nerve growth factor requires tyrosine phosphorylation of IkappaBalpha. J Cell Biol 152:753–764 Casazza K, Hanks LJ, Alvarez JA (2010) Role of various cytokines and growth factors in pubertal development. Med Sport Sci 55:14–31 Catley MC, Cambridge LM, Nasuhara Y, Ito K, Chivers JE, Beaton A, Holden NS, Bergmann MW, Barnes PJ, Newton R (2004) Inhibitors of protein kinase C (PKC) prevent activated transcription: role of events downstream of NF-kappaB DNA binding. J Biol Chem 279:18457–18466 Chen YL, Law PY, Loh HH (2006) Nuclear factor kappaB signaling in opioid functions and receptor gene expression. J Neuroimmune Pharmacol 1:270–279 Duran A, Diaz-Meco MT, Moscat J (2003) Essential role of RelA Ser311 phosphorylation by zetaPKC in NF-kappaB transcriptional activation. EMBO J 22:3910–3918 Easten KH, Harry RA, Purcell WM, McLeod JD (2009) Nociceptin-induced modulation of human T cell function. Peptides 30:926–934 Feng W, Song Y, Chen C, Lu ZZ, Zhang Y (2010) Stimulation of adenosine A(2B) receptors induces interleukin-6 secretion in cardiac fibroblasts via the PKC-delta-P38 signalling pathway. Br J Pharmacol 159:1598–1607 Finley MJ, Happel CM, Kaminsky DE, Rogers TJ (2008) Opioid and nociceptin receptors regulate cytokine and cytokine receptor expression. Cell Immunol 252:146–154 Fiset ME, Gilbert C, Poubelle PE, Pouliot M (2003) Human neutrophils as a source of nociceptin: a novel link between pain and inflammation. Biochemistry 42:10498–10505 Fu X, Zhu ZH, Wang YQ, Wu GC (2007) Regulation of proinflammatory cytokines gene expression by nociceptin/orphanin FQ in the spinal cord and the cultured astrocytes. Neuroscience 144:275–285 Gilmore TD (2006) Introduction to NF-kappaB: players, pathways, perspectives. Oncogene 25:6680–6684 Halford WP, Gebhardt BM, Carr DJ (1995) Functional role and sequence analysis of a lymphocyte orphan opioid receptor. J Neuroimmunol 59:91–101 Hao F, Tan M, Wu DD, Xu X, Cui MZ (2010) LPA induces IL-6 secretion from aortic smooth muscle cells via an LPA1-regulated, PKC-dependent, and p38alpha-mediated pathway. Am J Physiol Heart Circ Physiol 298:H974–H983 Happel C, Kutzler M, Rogers TJ (2011) Opioid-induced chemokine expression requires NF-{kappa}B activity: the role of PKC{zeta}. J Leukoc Biol 89:301–309 Khairova RA, Machado-Vieira R, Du J, Manji HK (2009) A potential role for pro-inflammatory cytokines in regulating synaptic plasticity in major depressive disorder. Int J Neuropsychopharmacol 12:561–578 Khalaf H, Jass J, Olsson PE (2010) Differential cytokine regulation by NF-kappaB and AP-1 in Jurkat T-cells. BMC Immunol 11:26 Kuzmin A, Madjid N, Johansson B, Terenius L, Ogren SO (2009) The nociceptin system and hippocampal cognition in mice: a pharmacological and genetic analysis. Brain Res 1305(Suppl):S7–S19 Lambert DG (2008) The nociceptin/orphanin FQ receptor: a target with broad therapeutic potential. Nat Rev Drug Discov 7:694–710 Levenson J, Pizzi M, Sweatt JD (2006) NF-KB/Rel transcription factor family. Landes Bioscience, Austin Li S, Wang L, Dorf ME (2009) PKC phosphorylation of TRAF2 mediates IKKalpha/beta recruitment and K63-linked polyubiquitination. Mol Cell 33:30–42 Liu AM, Wong YH (2005) Mu-opioid receptor-mediated phosphorylation of IkappaB kinase in human neuroblastoma SH-SY5Y cells. Neurosignals 14:136–142 Lou LG, Ma L, Pei G (1997) Nociceptin/orphanin FQ activates protein kinase C, and this effect is mediated through phospholipase C/Ca2+ pathway. Biochem Biophys Res Commun 240:304–308 Lu ZG, Liu H, Yamaguchi T, Miki Y, Yoshida K (2009) Protein kinase Cdelta activates RelA/p65 and nuclear factor-kappaB signaling in response to tumor necrosis factor-alpha. Cancer Res 69:5927–5935 Mandyam CD, Thakker DR, Christensen JL, Standifer KM (2002) Orphanin FQ/nociceptin-mediated desensitization of opioid receptor-like 1 receptor and mu opioid receptors involves protein kinase C: a molecular mechanism for heterologous cross-talk. J Pharmacol Exp Ther 302:502–509 Martiny-Baron G, Kazanietz MG, Mischak H, Blumberg PM, Kochs G, Hug H, Marme D, Schachtele C (1993) Selective inhibition of protein kinase C isozymes by the indolocarbazole Go 6976. J Biol Chem 268:9194–9197 Matsubara M, Tamura T, Ohmori K, Hasegawa K (2005) Histamine H1 receptor antagonist blocks histamine-induced proinflammatory cytokine production through inhibition of Ca2+-dependent protein kinase C, Raf/MEK/ERK and IKK/I kappa B/NF-kappa B signal cascades. Biochem Pharmacol 69:433–449 McAfoose J, Baune BT (2009) Evidence for a cytokine model of cognitive function. Neurosci Biobehav Rev 33:355–366 Memet S (2006) NF-kappaB functions in the nervous system: from development to disease. Biochem Pharmacol 72:1180–1195 Miller TR, Fulford AJ (2007) Regulation of nociceptin/orphaninFQ secretion by immune cells and functional modulation of interleukin-2. Peptides 28:2243–2252 Mut M, Amos S, Hussaini IM (2010) PKC alpha phosphorylates cytosolic NF-kappaB/p65 and PKC delta delays nuclear translocation of NF-kappaB/p65 in U1242 glioblastoma cells. Turk Neurosurg 20:277–285 Neal CR Jr, Akil H, Watson SJ Jr (2001) Expression of orphanin FQ and the opioid receptor-like (ORL1) receptor in the developing human and rat brain. J Chem Neuroanat 22:219–249 Park KM, Bowers WJ (2010) Tumor necrosis factor-alpha mediated signaling in neuronal homeostasis and dysfunction. Cell Signal 22:977–983 Peluso J, LaForge KS, Matthes HW, Kreek MJ, Kieffer BL, Gaveriaux-Ruff C (1998) Distribution of nociceptin/orphanin FQ receptor transcript in human central nervous system and immune cells. J Neuroimmunol 81:184–192 Peluso J, Gaveriaux-Ruff C, Matthes HW, Filliol D, Kieffer BL (2001) Orphanin FQ/nociceptin binds to functionally coupled ORL1 receptors on human immune cell lines and alters peripheral blood mononuclear cell proliferation. Brain Res Bull 54:655–660 Perdew GH, Vanden Heuval JP, Peters JM (2006) Regulation of gene expression: molecular mechanisms. Humana, Totowa Serhan CN, Fierro IM, Chiang N, Pouliot M (2001) Cutting edge: nociceptin stimulates neutrophil chemotaxis and recruitment: inhibition by aspirin-triggered-15-epi-lipoxin A4. J Immunol 166:3650–3654 Shinohara H, Yasuda T, Aiba Y, Sanjo H, Hamadate M, Watarai H, Sakurai H, Kurosaki T (2005) PKC beta regulates BCR-mediated IKK activation by facilitating the interaction between TAK1 and CARMA1. J Exp Med 202:1423–1431 Smith M, Delbary-Gossart S (2001) Electrophoretic mobility shift assay (EMSA). Humana, Totowa Spooren A, Kolmus K, Laureys G, Clinckers R, De Keyser J, Haegeman G, Gerlo S (2011) Interleukin-6, a mental cytokine. Brain Res Rev (in press) Thakker DR, Standifer KM (2002a) Induction of G protein-coupled receptor kinases 2 and 3 contributes to the cross-talk between mu and ORL1 receptors following prolonged agonist exposure. Neuropharmacology 43:979–990 Thakker DR, Standifer KM (2002b) Orphanin FQ/nociceptin blocks chronic morphine-induced tyrosine hydroxylase upregulation. Brain Res Mol Brain Res 105:38–46 Thakker DR, Altememi GF, Mandyam CD, Ibrahim H, Ramirez VI, Standifer KM (2007) Naloxone benzoylhydrazone activates extracellular signal-regulated protein kinases and modulates nociceptin opioid peptide receptor activity. Am J Pharmacol Toxicol 2:51–59 Tian L, Rauvala H, Gahmberg CG (2009) Neuronal regulation of immune responses in the central nervous system. Trends Immunol 30:91–99 Turner NA, Rumsby MG, Walker JH, McMorris FA, Ball SG, Vaughan PF (1994) A role for protein kinase C subtypes alpha and epsilon in phorbol-ester-enhanced K(+)- and carbachol-evoked noradrenaline release from the human neuroblastoma SH-SY5Y. Biochem J 297(Pt 2):407–413 Uceyler N, Schafers M, Sommer C (2009) Mode of action of cytokines on nociceptive neurons. Exp Brain Res 196:67–78 Viatour P, Merville MP, Bours V, Chariot A (2005) Phosphorylation of NF-kappaB and IkappaB proteins: implications in cancer and inflammation. Trends Biochem Sci 30:43–52 Waits PS, Purcell WM, Fulford AJ, McLeod JD (2004) Nociceptin/orphanin FQ modulates human T cell function in vitro. J Neuroimmunol 149:110–120 Wick MJ, Minnerath SR, Roy S, Ramakrishnan S, Loh HH (1995) Expression of alternate forms of brain opioid ‘orphan’ receptor mRNA in activated human peripheral blood lymphocytes and lymphocytic cell lines. Brain Res Mol Brain Res 32:342–347 Ye RD (2001) Regulation of nuclear factor kappaB activation by G-protein-coupled receptors. J Leukoc Biol 70:839–848 Zaveri NT, Waleh N, Toll L (2006) Regulation of the prepronociceptin gene and its effect on neuronal differentiation. Gene 384:27–36 Zeidman R, Pettersson L, Sailaja PR, Truedsson E, Fagerstrom S, Pahlman S, Larsson C (1999) Novel and classical protein kinase C isoforms have different functions in proliferation, survival and differentiation of neuroblastoma cells. Int J Cancer 81:494–501